Cite
Han MK, Ray R, Foo J, et al. Author Correction: Systematic literature review and meta-analysis of US-approved LAMA/LABA therapies versus tiotropium in moderate-to-severe COPD. NPJ Prim Care Respir Med. 2021;31(1):49doi: 10.1038/s41533-021-00264-6.
Han, M. K., Ray, R., Foo, J., Morel, C., & Hahn, B. (2021). Author Correction: Systematic literature review and meta-analysis of US-approved LAMA/LABA therapies versus tiotropium in moderate-to-severe COPD. NPJ primary care respiratory medicine, 31(1), 49. https://doi.org/10.1038/s41533-021-00264-6
Han, MeiLan K, et al. "Author Correction: Systematic literature review and meta-analysis of US-approved LAMA/LABA therapies versus tiotropium in moderate-to-severe COPD." NPJ primary care respiratory medicine vol. 31,1 (2021): 49. doi: https://doi.org/10.1038/s41533-021-00264-6
Han MK, Ray R, Foo J, Morel C, Hahn B. Author Correction: Systematic literature review and meta-analysis of US-approved LAMA/LABA therapies versus tiotropium in moderate-to-severe COPD. NPJ Prim Care Respir Med. 2021 Dec 15;31(1):49. doi: 10.1038/s41533-021-00264-6. PMID: 34911957.
Copy
Download .nbib